Home > Journals > Minerva Biotechnology and Biomolecular Research > Past Issues > Minerva Biotecnologica 2004 June;16(2) > Minerva Biotecnologica 2004 June;16(2):135-43

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

ORIGINAL ARTICLES  CELLULAR AND MOLECULAR ADVANCES IN THE STUDY OF INFLAMMATION 

Minerva Biotecnologica 2004 June;16(2):135-43

Copyright © 2004 EDIZIONI MINERVA MEDICA

language: English

Induction of apoptosis of human osteoclasts by the transcription factor decoy approach: relevance for the treatment of rheumatoid arthritis

Piva R. 1, Gambari R. 1, 2

1 Department of Biochemistry and Molecular Biology, University of Ferrara, Ferrara, Italy; 2 Interdisciplinary Center for Studies on Inflammation, University of Ferrara, Ferrara, Italy


PDF


Rheumatoid arthritis (RA) is characterised by the presence of an inflammatory synovitis accompanied by destruction of joint cartilage and bone. Several evidences, both in vitro and in animal models, indicate that osteoclasts (OCs) are key mediators of all forms of bone erosions and loss in RA. Interestingly, transcription factor decoy (TFD) oligonucleotides targeting nuclear factor κB (NF-kB) are able to induce apoptosis of human primary OCs. This effect is associated with an increase of caspase-3 and a decrease of interleukin-6 production. Therefore, the effects of NF-kB decoys on OCs may be relevant for the development of treatments of RA. Accordingly, several evidences suggest apoptosis as a target for therapy of this inflammatory disease.

top of page